Effects of Statin Combinations on Zika Virus Infection in Vero Cells
The Zika virus (ZIKV) remains a global health concern. Thus far, no antiviral or vaccine has been approved to prevent or treat ZIKV infection. In a previous study, we found that lipophilic statins can inhibit ZIKV production in Vero cells. These statins appear to have different potencies against ZIK...
Main Authors: | Erica Españo, Jeong-Ki Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/50 |
Similar Items
-
Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus
by: Juan-Carlos Saiz, et al.
Published: (2018-08-01) -
Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference
by: Alexandre Sze, et al.
Published: (2017-10-01) -
Zika Virus Inhibitors Based on a 1,3-Disubstituted 1<i>H</i>-Pyrazolo[3,4-<i>d</i>]pyrimidine-amine Scaffold
by: Eunkyung Jung, et al.
Published: (2022-09-01) -
In Vitro Inhibition of Zika Virus Replication with Poly(Sodium 4-Styrenesulfonate)
by: Paweł Botwina, et al.
Published: (2020-08-01) -
4,7-Disubstituted 7<i>H</i>-Pyrrolo[2,3-d]pyrimidines and Their Analogs as Antiviral Agents against Zika Virus
by: Ruben Soto-Acosta, et al.
Published: (2021-06-01)